Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| MapLight Therapeutics, Inc. | 175 964 | déclaré | 11 mai 2026 | tx 13+176 269−53 841 |
| PhaseBio Pharmaceuticals Inc | 8 463 | déclaré | 20 mai 2022 | tx 9+271 713 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 11 mai 2026 | SALE | MapLight Therapeutics, Inc. | 284 | 27.61 USD | 10b5-1 |
| 11 mai 2026 | SALE | MapLight Therapeutics, Inc. | 846 | 28.70 USD | 10b5-1 |
| 11 mai 2026 | SALE | MapLight Therapeutics, Inc. | 6 979 | 30.04 USD | 10b5-1 |
| 11 mai 2026 | SALE | MapLight Therapeutics, Inc. | 5 808 | 30.56 USD | 10b5-1 |
| 04 mai 2026 | SALE | MapLight Therapeutics, Inc. | 9 030 | 27.50 USD | 10b5-1 |
| 04 mai 2026 | SALE | MapLight Therapeutics, Inc. | 3 908 | 28.29 USD | 10b5-1 |
| 04 mai 2026 | SALE | MapLight Therapeutics, Inc. | 296 | 29.56 USD | 10b5-1 |
| 04 mai 2026 | SALE | MapLight Therapeutics, Inc. | 683 | 30.08 USD | 10b5-1 |
| 05 févr. 2026 | GRANT_AWARD | MapLight Therapeutics, Inc. | 7 730 | 0.00 USD | |
| 05 févr. 2026 | GRANT_AWARD | MapLight Therapeutics, Inc. | 31 395 | 0.00 USD | deriv |
| 27 janv. 2026 | TAX_WITHHOLDING | MapLight Therapeutics, Inc. | 26 007 | 17.98 USD | |
| 27 oct. 2025 | GRANT_AWARD | MapLight Therapeutics, Inc. | 27 098 | 0.00 USD | |
| 27 oct. 2025 | GRANT_AWARD | MapLight Therapeutics, Inc. | 110 046 | 0.00 USD | deriv |
| 20 mai 2022 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 4 831 | 0.68 USD | |
| 24 févr. 2022 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 87 500 | 0.00 USD | deriv |
| 24 févr. 2022 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 18 750 | 0.00 USD | deriv |
| 19 nov. 2021 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 1 545 | 2.01 USD | |
| 20 mai 2021 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 1 088 | 2.80 USD | |
| 05 févr. 2021 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 36 000 | 0.00 USD | deriv |
| 20 nov. 2020 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 999 | 3.00 USD | |
| 12 févr. 2020 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 55 000 | 0.00 USD | deriv |
| 07 oct. 2019 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 66 000 | 0.00 USD | deriv |